Coronado Biosciences, Inc. (CNDO):企業概要、財務及び戦略的SWOT分析

◆英語タイトル:Coronado Biosciences, Inc. (CNDO) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH135290FSA
◆発行会社(調査会社):GlobalData
◆発行日:2015年1月9日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD300 ⇒換算¥33,300見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥66,600見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD900 ⇒換算¥99,900見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary

Coronado Biosciences, Inc., (Coronado Biosciences) is a biopharmaceutical company. The company develops novel immunotherapy biologic agents for autoimmune diseases and cancer. Its products pipeline includes TSO and CNDO-109. Coronado Biosciences’ TSO product includes autoimmune therapeutics market, hygiene hypothesis, immune system and autoimmune disease, inflammatory bowel disease and multiple sclerosis. The company’s CNDO-109 products include oncology therapeutics market and AML. Its pharmaceutical product candidates are mainly targeted for clinical development for inflammatory bowel disease, multiple sclerosis and acute myeloid leukemia. The company collaborates with OvaMed and Dr. Falk Pharma GmbH for the development of TSO for Crohn’s disease. Coronado Biosciences is headquartered in Burlington, Massachusetts, the US.

Coronado Biosciences, Inc. Key Recent Developments

Dec 20, 2013: Coronado Biosciences Announces Management Changes
Nov 06, 2013: Coronado Biosciences Announces Personnel Realignment, Including Appointment of Kevin Horgan, M.D., as Chief Medical Officer
Nov 01, 2013: Coronado Biosciences Reports Financial Results for the Third Quarter Ended September 30, 2013
Sep 03, 2013: Coronado Biosciences to Present at Upcoming Healthcare Investor Conferences
Aug 27, 2013: Coronado Biosciences to Participate in Citi’s 8th Annual Biotech Conference

This comprehensive SWOT profile of Coronado Biosciences, Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Coronado Biosciences, Inc. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Coronado Biosciences, Inc. – Key Information
Coronado Biosciences, Inc. – Overview
Coronado Biosciences, Inc. – Key Employees
Coronado Biosciences, Inc. – Key Employee Biographies
Coronado Biosciences, Inc. – Key Operational Heads
Coronado Biosciences, Inc. – Major Products and Services
Coronado Biosciences, Inc. – History
Coronado Biosciences, Inc. – Company Statement
Coronado Biosciences, Inc. – Locations And Subsidiaries
Coronado Biosciences, Inc. – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Coronado Biosciences, Inc. – Business Description
Coronado Biosciences, Inc. – Corporate Strategy
Coronado Biosciences, Inc. – SWOT Analysis
SWOT Analysis – Overview
Coronado Biosciences, Inc. – Strengths
Coronado Biosciences, Inc. – Weaknesses
Coronado Biosciences, Inc. – Opportunities
Coronado Biosciences, Inc. – Threats
Coronado Biosciences, Inc. – Key Competitors

Section 3 – Company Financial Performance Charts

Coronado Biosciences, Inc. – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Coronado Biosciences, Inc., Key Information
Coronado Biosciences, Inc., Key Ratios
Coronado Biosciences, Inc., Share Data
Coronado Biosciences, Inc., Major Products and Services
Coronado Biosciences, Inc., History
Coronado Biosciences, Inc., Key Employees
Coronado Biosciences, Inc., Key Employee Biographies
Coronado Biosciences, Inc., Key Operational Heads
Coronado Biosciences, Inc., Other Locations
Coronado Biosciences, Inc., Subsidiaries
Coronado Biosciences, Inc., Key Manufacturing facilities
Coronado Biosciences, Inc., Key Competitors
Coronado Biosciences, Inc., SWOT Analysis
Coronado Biosciences, Inc., Ratios based on current share price
Coronado Biosciences, Inc., Annual Ratios
Coronado Biosciences, Inc., Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Coronado Biosciences, Inc., Performance Chart
Coronado Biosciences, Inc., Ratio Charts

★海外企業調査レポート[Coronado Biosciences, Inc. (CNDO):企業概要、財務及び戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Momenta Pharmaceuticals, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Momenta Pharmaceuticals, Inc. M …
  • DXP Enterprises, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' DXP Enterprises, Inc. Mergers a …
  • CVR Energy, Inc.:企業の戦略・SWOT・財務分析
    SummaryCVR Energy, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findin …
  • Capital One Financial Corporation:企業の戦略・SWOT・財務分析
    Capital One Financial Corporation - Strategy, SWOT and Corporate Finance Report Summary Capital One Financial Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • PsiOxus Therapeutics Ltd-製薬・医療分野:企業M&A・提携分析
    Summary PsiOxus Therapeutics Ltd (PsiOxus), formerly known as Myotec Therapeutics Ltd, is a drug company that develops novel therapeutics for cancer and other clinically unmet diseases. The company's pipeline product portfolio includes an oncolytic vaccine and a dual action anabolic catabolic transf …
  • Simba Energy Inc. (SMB):企業のM&A・提携動向(石油・ガス分野)
    Summary Simba Energy Inc. (Simba Energy), formerly Gold Star Resources Corp, is an oil and gas exploration company. It focuses its exploration activities on the onshore frontier basins of Africa. The company’s portfolio includes onshore Production Sharing Contracts (PSC) in Chad, Kenya and Guinea. S …
  • Philips Healthcare-製薬・医療分野:企業M&A・提携分析
    Summary Philips Healthcare, formerly Philips Medical Systems, undertakes the manufacture and distribution of diagnostic imaging systems, healthcare information technology solutions, patient monitoring and cardiac devices. Philips Healthcare is a division of Royal Philips Electronics of the Netherlan …
  • Pharma Foods International Co., Ltd. (2929):企業概要、財務及び戦略的SWOT分析
    Summary Pharma Foods International Co., Ltd. (Pharma Foods) is a pharmaceutical company. The company provides functional food ingredients and health food products. Its products include Ovopron, Pharma-GABA, tasty catechin, alpha lipoic acid, Bonepep, Runpep and folic acid egg. The company’s product …
  • Halfords Group plc (HFD):企業の財務・戦略的SWOT分析
    Halfords Group plc (HFD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • China National Petroleum Corporation (CNPC):企業の戦略・SWOT・財務分析
    SummaryChina National Petroleum Corporation (CNPC) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view …
  • Innovate Biopharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Innovate Biopharmaceuticals Inc (Innovate) is a clinical stage biotechnology company that develops novel medicines for gastroenterological and orphan disorders. The company’s pipeline product includes INN-329 in phase III for magnetic resonance cholangiopancreatography; and INN-108 in phase …
  • OAO Roskommunenergo:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' OAO Roskommunenergo Mergers and …
  • The Ultimate Software Group, Inc. (ULTI):企業の財務・戦略的SWOT分析
    The Ultimate Software Group, Inc. (ULTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Alvogen Korea Co Ltd (002250):企業財務及び戦略的SWOT分析
    Summary Alvogen Korea Co Ltd (Alvogen), a subsidiary of Alvogen Inc is a pharmaceutical company that manufactures and commercializes prescription pharmaceuticals for use in various therapeutic areas. The company offers products which include amlomax tablets, alfurix XL tablets, aropotin prefilled in …
  • Empyrean Energy PLC (EME):企業概要、財務及び戦略的SWOT分析
    Summary Empyrean Energy PLC (Empyrean Energy) is an oil and gas company. The company explores, develops and produces energy resource projects. Its projects include Sugarloaf project, Riverbend project in Texas; and Eagle Oil Pool Development, California. The company has interest in Kennedy IH Well a …
  • ASKA Pharmaceutical Co., Ltd. (4514):企業の財務及び戦略的SWOT分析
    Summary ASKA Pharmaceutical Co., Ltd. (ASKA) is a pharmaceutical company that develops and markets pharmaceuticals, quasi-drugs, foods, medical devices and veterinary medicines. The company also imports and exports pharmaceuticals and medical devices. Its activities include production, drug informat …
  • Carr’s Milling Industries PLC (CRM):企業概要、財務及び戦略的SWOT分析
    Carr's Milling Industries PLC (CRM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Prime Polymer Co., Ltd.:企業の戦略的SWOT分析
    Prime Polymer Co., Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Ceylon Hospitals PLC (CHL.N0000):企業概要、財務及び戦略的SWOT分析
    Summary Ceylon Hospitals PLC (Ceylon) is a healthcare service provider. The hospital offers blood bank, dietetic and nutritional care, EEG services, laboratory services, pharmacy, radiology and imaging and, specialists consultations. It provides services in the areas of audiology, speech and languag …
  • Top Glove Corporation Berhad (TOPGLOV):企業の財務及び戦略的SWOT分析
    Summary Top Glove Corporation Berhad (Top Glove) is a rubber gloves manufacturing company that offers a diverse range of glove products and services in the healthcare and non-healthcare segment. It develops products such as latex gloves, nitrile gloves, vinyl gloves, surgical gloves, household glove …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆